Drug ligand-induced activation of translocator protein (TSPO) stimulates steroid production by aged Brown Norway rat leydig cells

Endocrinology

Volumn 154, Issue 6, 2013, Pages 2156-2165

  Chung, J Y ^a   Chen, H ^a   Midzak, A ^c   Burnett, A L ^b   Papadopoulos, V ^c   Zirkin, Barry R ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 ANDROSTEN 3,17,19 TRIOL; BENZODIAZEPINE 4' CHLORODIAZEPAM; BINDING PROTEIN; FGIN 1 27; LIGAND; N,N DIHEXYL 2 (4 FLUOROPHENYL)INDOLE 3 ACETAMIDE; RO5 4864; STEROID; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; HYPOGONADISM; IN VITRO STUDY; IN VIVO STUDY; LEYDIG CELL; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; STEROIDOGENESIS; T LYMPHOCYTE; TUMOR CELL;

AGE FACTORS; ANDROSTENOLS; ANIMALS; BENZODIAZEPINONES; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLEACETIC ACIDS; LEYDIG CELLS; MALE; MICE; RATS; RATS, INBRED BN; RECEPTORS, GABA; STEROIDS; TESTIS;

EID: 84878451131     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2226     Document Type: Article

References (70)

1. Catt KJ, Hardwood JP, Clayton RN, et al. Regulation of peptide hormone receptors and gonadal steroidogenesis. Rec Prog Horm Res. 1980;36:557-662.
2. Simpson ER, Waterman MR. Regulation by ACTH of steroid hormone biosynthesis in the adrenal cortex. Can J Biochem Cell Biol. 1983;61:692-707. (Pubitemid 13015483)
3. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004;25:947-970. (Pubitemid 39657774)
4. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994;269:28314-28322.
5. Stocco DM. Tracking the role of a star in the sky of the new millennium. Mol Endocrinol. 2001;15:1245-1254. (Pubitemid 32703474)
6. Papadopoulos V, Mukhin AG, Costa E, Krueger KE. The peripheraltype benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem. 1990;265:3772-3779.
7. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402-409. (Pubitemid 44069585)
8. Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 1996;17:221-244. (Pubitemid 26001082)
9. Strauss JF 3rd, Kallen CB, Christenson LK, et al. The steroidogenic acute regulatory protein (StAR): a window into the complexities of intracellular cholesterol trafficking. Recent Prog Horm Res. 1999;54:369-394.
10. Tuckey RC, Headlam MJ, Bose HS, Miller WL. Transfer of cholesterol between phospholipid vesicles mediated by the steroidogenic acute regulatory protein (StAR). J Biol Chem. 2002;277:47123-47128. (Pubitemid 36159221)
11. Miller ML. Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochim Biophys Acta. 2007;1771:663-676.
12. Strauss JF 3rd, Kishida T, Christenson LK, Fujimoto T, Hiroi H. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol Cell Endocrinol. 2003;202:59-65. (Pubitemid 36603365)
13. Alpy F, Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J Cell Sci. 2005;118:2791-2801. (Pubitemid 41136357)
14. Roostaee A, Barbar E, Lehoux JG, Lavigne P. Cholesterol binding is a prerequisite for the activity of the steroidogenic acute regulatory protein (StAR). Biochem J. 2008;412:553-562. (Pubitemid 351846421)
15. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr Rev. 1993;14:222-240. (Pubitemid 23118419)
16. Scarf AM, Kassiou M. The translocator protein. J Nucl Med. 2011;52:677-680.
17. Midzak A, Rone M, Aghazadeh Y, Culty M, Papadopoulos V. Mitochondrial protein import and the genesis of steroidogenic mitochondria. Mol Cell Endocrinol. 2011;336:70-79.
18. Li H, Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology. 1998;139:4991-4997. (Pubitemid 28533447)
19. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V. Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA. 2001;98:1267-1272. (Pubitemid 32121221)
20. Lacapère JJ, Delavoie F, Li H, et al. Structural and functional study of reconstituted peripheral benzodiazepine receptor. Biochem Biophys Res Commun. 2001;284:536-541. (Pubitemid 32918011)
21. Jamin N, Neumann JM, Ostuni MA, et al. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol. 2005;19:588-594. (Pubitemid 40349433)
22. Murail S, Robert JC, Coïc YM, et al. Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding. Biochim Biophys Acta. 2008;1778:1375-1381.
23. Papadopoulos V, Amri H, Li H, Boujrad N, Vidic B, Garnier M. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem. 1997;272:32129-32135. (Pubitemid 28011885)
24. Amri H, Ogwuegbu SO, Boujrad N, Drieu K, Papadopoulos V. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides. Endocrinology. 1996;137:5707-5718. (Pubitemid 26423144)
25. Sridaran R, Philip GH, Li H, et al. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy. J Mol Endocrinol. 1999;22:45-54. (Pubitemid 29083455)
26. Zilz A, Li H, Castello R, Papadopoulos V, Widmaier EP. Developmental expression of the peripheral-type benzodiazepine receptor and the advent of steroidogenesis in rat adrenal glands. Endocrinology. 1999;140:859-864. (Pubitemid 29058223)
27. Culty M, Luo L, Yao ZX, Chen H, Papadopoulos V, Zirkin BR. Cholesterol transport, peripheral benzodiazepine receptor, and steroidogenesis in aging Leydig cells. J Androl. 2002;23:439-447. (Pubitemid 34297333)
28. Amri H, Drieu K, Papadopoulos V. Transcriptional suppression of the adrenal cortical peripheral-type benzodiazepine receptor gene and inhibition of steroid synthesis by ginkgolide B. Biochem Pharmacol. 2003;65:717-729. (Pubitemid 36293688)
29. Sun Z, Shen WJ, Leers Sucheta S, Azhar S. Impact of aging on cholesterol transport protein expression and steroidogenesis in rat testicular Leydig cells. Open Longev Sci. 2008;2:76-85.
30. Chen H, Hardy MP, Huhtaniemi I, Zirkin BR. Age-related decreased Leydig cell testosterone production in the Brown Norway rat. J Androl. 1994;15:551-557.
31. Midzak AS, Chen H, Papadopoulos V, Zirkin BR. Leydig cell aging and the mechanisms of reduced testosterone synthesis. Mol Cell Endocrinol. 2009;299:23-31.
32. Chen H, Ge RS, Zirkin BR. Leydig cells: from stem cells to aging. Mol Cell Endocrinol. 2009;306:9-16.
33. Chen H, Stanley E, Jin S, Zirkin BR. Stem Leydig cells: from fetal to aged animals. Birth Defects Res C Embryo Today. 2010;90:272-283.
34. Krueger KE, Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J Biol Chem. 1990;265:15015-15022.
35. Lacapere JJ, Papadopoulos V. Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids. 2003;68:569-585. (Pubitemid 37075920)
36. Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9:971-988.
37. Hauet T, Yao ZX, Bose HS, et al. Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into Leydig cell mitochondria. Mol Endocrinol. 2005;19:540-554. (Pubitemid 40223475)
38. Kozikowski AP, Kotoula M, Ma D, Boujrad N, Tückmantel W, Papadopoulos V. Synthesis and biology of a 7-nitro-2,1,3-benzox-adiazol-4-yl derivative of 2-phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptor. J Med Chem. 1997;40:2435-2439. (Pubitemid 27347006)
39. Midzak A, Rammouz G, Papadopoulos V. Structure-activity relationship (SAR) analysis of a family of steroids acutely controlling steroidogenesis. Steroids. 2012;77:1327-1334.
40. Klinefelter GR, Hall PF, Ewing LL. Effect of luteinizing hormone deprivation in situ on steroidogenesis of rat Leydig cells purified by a multistep procedure. Biol Reprod. 1987;36:769-783.
41. Midzak A, Akula N, Lecanu L, Papadopoulos V. Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. J Biol Chem. 2011;286:9875-9887.
42. Darney KJ Jr, Wing TY, Ewing LL. Simultaneous measurement of four testicular Δ4-3-ketosteroids by isocratic high-performance liquid chromatography with on-line ultraviolet absorbance detection. J Chromatogr. 1983;257:81-90. (Pubitemid 13079998)
43. Gazouli M, Han Z, Papadopoulos V. Identification of a peptide antagonist to the peripheral-type benzodiazepine receptor that inhibits hormone-stimulated Leydig cell steroid formation. J Pharmacol Exp Ther. 2002;303:627-632. (Pubitemid 35231234)
44. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724-731. (Pubitemid 32207487)
45. Swerdloff RS, Wang C. Androgens and the ageing male. Best Pract Res Clin Endocrinol Metab. 2004;18:349-362. (Pubitemid 38992416)
46. Sigman M, Howards S. Male infertility. In: Walsh PC, Retik AB, Vaughan ED Jr, eds. Campbell's Textbook of Urology. 7th ed. Philadelphia: W. B. Saunders Co; 1998.
47. Mohr BA, Guay AT, O'Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol. 2005;62:64-73. (Pubitemid 40175285)
48. Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241-4247. (Pubitemid 350074738)
49. Bhasin S, Basaria S. Diagnosis and treatment of hypogonadism in men. Best Prac Res Clin Endocrinol Metab. 2011;25:251-270.
50. Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol. 2012;2012:1-20.
51. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73:1016-1025. (Pubitemid 21901140)
52. Veldhuis JD, Veldhuis NJ, Keenan DM, Iranmanesh A. Age diminishes the testicular steroidogenic response to repeated intravenous pulses of recombinant human LH during acute GnRH-receptor blockade in healthy men. Am J Physiol Endocrinol Metab. 2005;288:E775-E778.
53. Kim, HH, Schlegel PN. Endocrine manipulation in male infertility. Urol Clin North Am. 2008;35:303-318. (Pubitemid 351514773)
54. Hwang K, Walters RC, Lipshultz LI. Contemporary concepts in the evaluation and management of male infertility. Nat Rev Urol. 2011;8:86-94.
55. Schlegel PN. Evaluation of male infertility. Minerva Ginecol. 2009;61:261-283.
56. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci. 2002;57:M76-M99. (Pubitemid 34177406)
57. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123-135.
58. Chen H, Huhtaniemi I, Zirkin BR. Depletion and repopulation of Leydig cells in the testes of aging brown Norway rats. Endocrinology. 1996;137:3447-3452. (Pubitemid 26250198)
59. Gruenewald DA, Naai MA, Hess DL, Matsumoto AM. The Brown Norway rat as a model of male reproductive aging: evidence for both primary and secondary testicular failure. J Gerontol. 1994;49:B42-B50. (Pubitemid 24100244)
60. Wang C, Leung A, Sinha-Hikim AP. Reproductive aging in the male brown-Norway rat: a model for the human. Endocrinology. 1993;133:2773-2781. (Pubitemid 24000735)
61. Papadopoulos V, Miller WL. Role of mitochondria in steroidogenesis. Best Pract Res Clin Endocrinol Metab. 2012;26:771-790.
62. Rone MB, Midzak AS, Issop L, et al. Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol Endocrinol. 2012;26:1868-1882.
63. Romeo E, Auta J, Kozikowski AP, et al. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J Pharmacol Exp Ther. 1992;262:971-978.
64. Luo L, Chen H, Zirkin BR. Temporal relationships among testosterone production, steroidogenic acute regulatory protein (StAR), and P450 side-chain cleavage enzyme (P450scc) during Leydig cell aging. J Androl. 2005;26:25-31. (Pubitemid 39665272)
65. Rone MB, Fan J, Papadopoulos V. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta. 2009;1791:646-658.
66. Miller WL, Bose HS. Early steps in steroidogenesis: intracellular cholesterol trafficking. J Lipid Res. 2011;52:2111-2135.
67. Chen H, Hardy MP, Zirkin BR. Age-related decreases in Leydig cell testosterone production are not restored by exposure to LH in vitro. Endocrinology. 2002;143:1637-1642. (Pubitemid 34415877)
68. Abadilla KA, Dobs AS. Topical testosterone supplementation for the treatment of male hypogonadism. Drugs. 2012;72:1591-1603.
69. Ramasamy R, Stahl PJ, Schlegel PN. Medical therapy for spermatogenic failure. Asian J Androl. 2011;14:57-60.
70. Luo L, Chen H, Zirkin BR. Are Leydig cell steroidogenic enzymes differentially regulated with aging? J Androl. 1996;17:509-515. (Pubitemid 26403611)